Showing results 36 to 43 of 43
< previous
Issue Date | Title | Author(s) |
2014 | Reforming the cancer drug fund focus on drugs that might be shown to be cost effective | Buxton, M; Longworth, L; Raftery, J; Sculpher, M; Towse, A |
2012 | A review of generic preference-based measures of health-related quality of life in visual disorders | Tosh, J; Brazier, J; Evans, P; Longworth, L |
9-Nov-2021 | Use of [<sup>177</sup>Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study | Glover, M; Caplin, M; Leeuwenkamp, OR; Longworth, L |
2014 | Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey | Longworth, L; Yang, Y; Young, T; Mulhern, B; Hernandez, M; Mukuria, C; Rowen, D; Tosh, J; Tsuchiya, A; Evans, P; Keetharuth, A; Brazier, J |
2014 | Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: systematic review, statistical modelling and survey. | Longworth, L; Yang, Y; Young, T; Hernandez Alva, M; Mukuria, C; Rowen, D; Tosh, J; Tsuchiya, A; Evans, P; Keetharuth, A; Brazier, J |
2016 | Utility of pain states: what influences the value people give to being in pain | Marciniak, Anne Marie |
2016 | What works for wellbeing in culture and sport? Report of a DELPHI process to support coproduction and establish principles and parameters of an evidence review | Daykin, N; Mansfield, L; Payne, A; Kay, T; Meads, C; DInnocenzo, G; Burnett, A; Dolan, P; Julier, G; Longworth, L; Tomlinson, A; Testoni, S; Victor, C |
2013 | When does NICE recommend the use of health technologies within a programme of evidence development? | Longworth, L; Youn, J; Bojke, L; Palmer, S; Griffin, S; Spackman, E; Claxton, K |